相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial
Antonio Omuro et al.
NEURO-ONCOLOGY (2023)
Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
Lalitha Palanivelu et al.
FRONTIERS IN IMMUNOLOGY (2023)
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control
Maria E. Rodriguez-Ruiz et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)
Apoptotic cell death in disease-Current understanding of the NCCD 2023
Ilio Vitale et al.
CELL DEATH AND DIFFERENTIATION (2023)
Immunogenic cell death in cancer: concept and therapeutic implications
Lorenzo Galluzzi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2023)
The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells
Sumit Sen Santara et al.
NATURE (2023)
Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2023)
Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy
Kailin Yang et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2023)
Autophagy and autophagy-related pathways in cancer
Jayanta Debnath et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2023)
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
Peng Zhang et al.
NATURE COMMUNICATIONS (2023)
The DNA Damage Response and Infl ammation in Cancer
Vanessa Klapp et al.
CANCER DISCOVERY (2023)
Immunogenic cell death after combined treatment with radiation and ATR inhibitors is dually regulated by apoptotic caspases
Adrian Eek Mariampillai et al.
FRONTIERS IN IMMUNOLOGY (2023)
Dynamics and specificities of T cells in cancer immunotherapy
Giacomo Oliveira et al.
NATURE REVIEWS CANCER (2023)
Nucleotide metabolism: a pan-cancer metabolic dependency
Nicholas J. J. Mullen et al.
NATURE REVIEWS CANCER (2023)
Therapeutic targeting of tumour myeloid cells
Simon T. Barry et al.
NATURE REVIEWS CANCER (2023)
TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective
Briana G. Nixon et al.
NATURE REVIEWS IMMUNOLOGY (2023)
Mitochondrial control of inflammation
Saverio Marchi et al.
NATURE REVIEWS IMMUNOLOGY (2023)
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
Qing Zhou et al.
LANCET ONCOLOGY (2022)
Immunogenic cell stress and death
Guido Kroemer et al.
NATURE IMMUNOLOGY (2022)
Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer
Giulia Petroni et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
Hirohito Yamaguchi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Identification of neoantigens for individualized therapeutic cancer vaccines
Franziska Lang et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Pharmacological targeting of endoplasmic reticulum stress in disease
Stefan J. Marciniak et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients
Kerstin Clasen et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2022)
Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration
Taiki Moriya et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
Giulia Petroni et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
Michael Lim et al.
NEURO-ONCOLOGY (2022)
Combination of OX40 Co-Stimulation, Radiotherapy, and PD-1 Inhibition in a Syngeneic Murine Triple-Negative Breast Cancer Model
Min Guk Han et al.
CANCERS (2022)
Macrophages as tools and targets in cancer therapy
Alberto Mantovani et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
Rodney Cheng-En Hsieh et al.
SCIENCE IMMUNOLOGY (2022)
Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect
Yoko Nishiga et al.
NATURE CANCER (2022)
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Martina Musella et al.
NATURE IMMUNOLOGY (2022)
PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes
Cristina C. Clement et al.
SCIENCE IMMUNOLOGY (2022)
Developing dietary interventions as therapy for cancer
Samuel R. Taylor et al.
NATURE REVIEWS CANCER (2022)
A guide to antigen processing and presentation
Novalia Pishesha et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Context-dependent functions of pattern recognition receptors in cancer
Si Ming Man et al.
NATURE REVIEWS CANCER (2022)
Radiotherapy and immunotherapy: open questions and future strategies
Kelli B. Pointer et al.
TRENDS IN CANCER (2022)
Regulation of the nucleic acid-sensing Toll-like receptors
Nicholas A. Lind et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
Urszula M. Cytlak et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Interferon-γ: teammate or opponent in the tumour microenvironment?
Angela M. Gocher et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Natural killer cells in antiviral immunity
Niklas K. Bjorkstrom et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Immunomodulation by targeted anticancer agents
Giulia Petroni et al.
CANCER CELL (2021)
Geographic Density of Linear Accelerators and Receipt of Radiation Therapy for Prostate Cancer
J.E. Bates et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control
Claire Lhuillier et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
The injury response to DNA damage in live tumor cells promotes antitumor immunity
Ganapathy Sriram et al.
SCIENCE SIGNALING (2021)
Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery
Cristina C. Clement et al.
IMMUNITY (2021)
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Nancy Y Lee et al.
LANCET ONCOLOGY (2021)
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
ATP and cancer immunosurveillance
Oliver Kepp et al.
EMBO JOURNAL (2021)
Infection-induced type I interferons critically modulate the homeostasis and function of CD8+ naive T cells
Mladen Jergovic et al.
NATURE COMMUNICATIONS (2021)
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides
Ilio Vitale et al.
TRENDS IN CANCER (2021)
Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
Autophagy in tumour immunity and therapy
Houjun Xia et al.
NATURE REVIEWS CANCER (2021)
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala et al.
NATURE REVIEWS CANCER (2021)
Endoplasmic reticulum stress signals in the tumour and its microenvironment
Xi Chen et al.
NATURE REVIEWS CANCER (2021)
Calreticulin and cancer
Jitka Fucikova et al.
CELL RESEARCH (2021)
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients
Iva Truxova et al.
HAEMATOLOGICA (2020)
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
Simer J. Bains et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
Maria Esperanza Rodriguez-Ruiz et al.
NATURE IMMUNOLOGY (2020)
CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model
Hidenori Tsukui et al.
BMC CANCER (2020)
Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress
Juliette Humeau et al.
EMBO MOLECULAR MEDICINE (2020)
CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection
Erik Wennerberg et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Keisuke Yamamoto et al.
NATURE (2020)
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling
Chuanhui Han et al.
NATURE IMMUNOLOGY (2020)
Targeting apoptosis in cancer therapy
Benedito A. Carneiro et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
The clearance of dead cells by efferocytosis
Emilio Boada-Romero et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Nucleic Acid Sensors as Therapeutic Targets for Human Disease
Sarah M. McWhirter et al.
IMMUNITY (2020)
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
Takahiro Yamazaki et al.
NATURE IMMUNOLOGY (2020)
The adenosine pathway in immuno-oncology
Bertrand Allard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Lorenzo Galluzzi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Antitumour dendritic cell vaccination in a priming and boosting approach
Alexandre Harari et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Opposing Roles of Type I Interferons in Cancer Immunity
Giselle M. Boukhaled et al.
Annual Review of Pathology-Mechanisms of Disease (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
The cancer-natural killer cell immunity cycle
Nicholas D. Huntington et al.
NATURE REVIEWS CANCER (2020)
Modulation of regulatory T cell function and stability by co-inhibitory receptors
Liliana E. Lucca et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Martin McLaughlin et al.
NATURE REVIEWS CANCER (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Tao Gong et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Enhancing cancer immunotherapy with nanomedicine
Darrell J. Irvine et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies
Maria E. Rodriguez-Ruiz et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Interferons α and β in cancer: therapeutic opportunities from new insights
Ernest C. Borden
NATURE REVIEWS DRUG DISCOVERY (2019)
High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy
Hongbing Ma et al.
CELL DEATH & DISEASE (2019)
Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors
Tadanobu Nagaya et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Sustained Type I Interferon Reinforces NK Cell-Mediated Cancer Immunosurveillance during Chronic Virus Infection
Ji Hoon Oh et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Radiotherapy toxicity
Dirk De Ruysscher et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Assessing the interactions between radiotherapy and antitumour immunity
Clemens Grassberger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Peng Liu et al.
NATURE COMMUNICATIONS (2019)
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy
Eric Deutsch et al.
LANCET ONCOLOGY (2019)
Lysosomes as a therapeutic target
Srinivasa Reddy Bonam et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles
Claire Vanpouille-Box et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Extracorporeal photochemotherapy induces bona fide immunogenic cell death
Kazuki Tatsuno et al.
CELL DEATH & DISEASE (2019)
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
Rumani Singh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Autophagy in the renewal, differentiation and homeostasis of immune cells
Alexander J. Clarke et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Calcium signalling in T cells
Mohamed Trebak et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng et al.
NATURE REVIEWS CANCER (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Cytosolic DNA Sensing in Organismal Tumor Control
Claire Vanpouille-Box et al.
CANCER CELL (2018)
Extracorporeal Photochemotherapy Drives Monocyte-to-Dendritic Cell Maturation to Induce Anticancer Immunity
Alessandra Ventura et al.
CANCER RESEARCH (2018)
Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer
Annemarie E. M. Post et al.
CLINICAL CANCER RESEARCH (2018)
Nano-Pulse Stimulation induces immunogenic cell death in human papillomavirus-transformed tumors and initiates an adaptive immune response
Joseph G. Skeate et al.
PLOS ONE (2018)
Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect
Maria E. Rodriguez-Ruiz et al.
TRENDS IN IMMUNOLOGY (2018)
Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment
Arunakumar Gangaplara et al.
PLOS PATHOGENS (2018)
Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs
Julie M. Diamond et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The hallmarks of successful anticancer immunotherapy
Lorenzo Galluzzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
Matthew J. Frank et al.
CANCER DISCOVERY (2018)
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Silvia C. Formenti et al.
NATURE MEDICINE (2018)
Using immunotherapy to boost the abscopal effect
Wilfred Ngwa et al.
NATURE REVIEWS CANCER (2018)
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment
Francesco Di Virgilio et al.
NATURE REVIEWS CANCER (2018)
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy
Lorenzo Galluzzi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling
Meng Michelle Xu et al.
IMMUNITY (2017)
cGAS surveillance of micronuclei links genome instability to innate immunity
Karen J. Mackenzie et al.
NATURE (2017)
Mitotic progression following DNA damage enables pattern recognition within micronuclei
Shane M. Harding et al.
NATURE (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity
Mikako Ogawa et al.
ONCOTARGET (2017)
A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
Anurag K. Singh et al.
CLINICAL CANCER RESEARCH (2017)
Mitochondrial DNA in innate immune responses and inflammatory pathology
A. Phillip West et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Dying cells actively regulate adaptive immune responses
Nader Yatim et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients
J. Fucikova et al.
BLOOD (2016)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer
Brittany A. Simone et al.
CELL CYCLE (2016)
The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death
Chiara Pozzi et al.
NATURE MEDICINE (2016)
The oncolytic peptide LTX-315 triggers immunogenic cell death
H. Zhou et al.
CELL DEATH & DISEASE (2016)
Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy
Ruth Exner et al.
CANCER MEDICINE (2016)
TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
Claire Vanpouille-Box et al.
CANCER RESEARCH (2015)
Mitochondrial DNA stress primes the antiviral innate immune response
A. Phillip West et al.
NATURE (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Live to die another way: modes of programmed cell death and the signals emanating from dying cells
Yaron Fuchs et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer
Jitka Fucikova et al.
FRONTIERS IN IMMUNOLOGY (2015)
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
Holly E. Barker et al.
NATURE REVIEWS CANCER (2015)
Type I interferons in infectious disease
Finlay McNab et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
A. Ko et al.
CELL DEATH AND DIFFERENTIATION (2014)
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
T. Yamazaki et al.
CELL DEATH AND DIFFERENTIATION (2014)
Molecular mechanisms of ATP secretion during immunogenic cell death
I. Martins et al.
CELL DEATH AND DIFFERENTIATION (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
High hydrostatic pressure induces immunogenic cell death in human tumor cells
Jitka Fucikova et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Sofia R. Gameiro et al.
ONCOTARGET (2014)
ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
Abhishek D. Garg et al.
AUTOPHAGY (2013)
Caloric restriction augments radiation efficacy in breast cancer
Anthony D. Saleh et al.
CELL CYCLE (2013)
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death
Isabelle Martins et al.
AUTOPHAGY (2012)
Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
Yoshiyuki Suzuki et al.
CANCER RESEARCH (2012)
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Abhishek D. Garg et al.
EMBO JOURNAL (2012)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer
Guo-Liang Yang et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy
Furong Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Radiation as an immunological adjuvant: current evidence on dose and fractionation
Sandra Demaria et al.
FRONTIERS IN ONCOLOGY (2012)
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
Byron C. Burnette et al.
CANCER RESEARCH (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
Role of Type 1 IFNs in Antiglioma Immunosurveillance-Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans
Mitsugu Fujita et al.
CLINICAL CANCER RESEARCH (2010)
Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance
Yong Liu et al.
EUROPEAN JOURNAL OF CANCER (2010)
Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma
Bita Boozari et al.
GUT (2010)
Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma
Xingjun Yao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Joshua D. Brody et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Autophagy regulates selective HMGB1 release in tumor cells that are destined to die
J. Thorburn et al.
CELL DEATH AND DIFFERENTIATION (2009)
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
M. Zahidunnabi Dewan et al.
CLINICAL CANCER RESEARCH (2009)
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
Theocharis Panaretakis et al.
EMBO JOURNAL (2009)
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Michael R. Elliott et al.
NATURE (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein
Hirotaka Kazama et al.
IMMUNITY (2008)
IFN-α skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo
Claudia Papewalis et al.
JOURNAL OF IMMUNOLOGY (2008)
Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma
D. Wu et al.
JOURNAL OF PATHOLOGY (2008)
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
Ralph R. Weichselbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
'Tuning' of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages
Lu Wang et al.
NATURE IMMUNOLOGY (2008)
Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis
M. Obeid et al.
CELL DEATH AND DIFFERENTIATION (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Calreticulin, a molecular chaperone in the endoplasmic reticulum, modulates radiosensitivity of human glioblastoma U251MG cells
Tomohiro Okunaga et al.
CANCER RESEARCH (2006)
The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas
Elizabeth W. Newcomb et al.
CLINICAL CANCER RESEARCH (2006)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte
SJ Gardai et al.
CELL (2005)
The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-α treatment
B Guillot et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Characterization of the type I interferon locus and identification of novel genes
MP Hardy et al.
GENOMICS (2004)
High mobility group box protein 1: An endogenous signal for dendritic cell maturation and Th1 polarization
D Messmer et al.
JOURNAL OF IMMUNOLOGY (2004)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)